Načítá se...

Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France

BACKGROUND: Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, this treatment is only available in a few countries via named patient programmes (NPPs). As a case study, the legal and organisational aspects and pharmacovigilance of these NPPs and possibilities for h...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kreeftmeijer-Vegter, Annemarie Rosan, van Veldhuizen, Cornelis KW, de Vries, Peter J
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848968/
https://ncbi.nlm.nih.gov/pubmed/24063858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-150
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!